Centogene N.V. announced a private placement to issue convertible loan for gross proceeds of $30 million on June 27, 2023. The transaction will include participation from new investor, Lifera. The loan will be convertible before 2024 into common stock at a conversion price of $2.20.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.385 USD | +1.16% | -15.47% | -70.41% |
May. 16 | Upcoming Slew of Economic Data Buoys Exchange-Traded Funds, Equity Futures Pre-Bell Thursday | MT |
May. 16 | Top Premarket Gainers | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-70.41% | 10.61M | |
+39.20% | 54.04B | |
+44.87% | 41.96B | |
-1.33% | 41.92B | |
-7.20% | 28.35B | |
+12.53% | 26.35B | |
-21.66% | 19B | |
+6.99% | 13B | |
+29.03% | 12.28B | |
+26.32% | 12.19B |
- Stock Market
- Equities
- CNTG Stock
- News Centogene N.V.
- Centogene N.V. announced that it expects to receive $30 million in funding from Lifera